Cargando…
Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
Despite evidence-based therapies, patients presenting with atherosclerosis involving more than one vascular bed, such as those with peripheral artery disease (PAD) and concomitant coronary artery disease (CAD), constitute a particularly vulnerable group characterized by enhanced residual long-term r...
Autores principales: | Magnani, Giulia, Denegri, Andrea, Gurgoglione, Filippo Luca, Barocelli, Federico, Indrigo, Elia, Catellani, Davide, Signoretta, Gianluca, Bettella, Alberto, Tuttolomondo, Domenico, Solinas, Emilia, Nicolini, Francesco, Niccoli, Giampaolo, Ardissino, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455400/ https://www.ncbi.nlm.nih.gov/pubmed/37629326 http://dx.doi.org/10.3390/jcm12165284 |
Ejemplares similares
-
Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
por: Brunetti, Natale Daniele, et al.
Publicado: (2019) -
Percutaneous Nephrolithotomy in Patients on Chronic Anticoagulant/Antiplatelet Therapy
por: Nerli, R B, et al.
Publicado: (2012) -
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001) -
Balancing Antiplatelet and Anticoagulant Therapies in Patients with Cardiovascular Disease
por: Carreras, Edward T., et al.
Publicado: (2013) -
Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
por: Beitelshees, Amber L, et al.
Publicado: (2015)